<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: GlaxoSmithKline (Web)</title><link>http://www.zibb.com/all/theme/cq/GlaxoSmithKline</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/GlaxoSmithKline" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Thu, 05 Jul 2007 00:00:00 GMT</pubDate><lastBuildDate>Thu, 05 Jul 2007 00:00:00 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: GlaxoSmithKline (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/GlaxoSmithKline</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Top CPOs Audiocast: Gregg Brandyberry, vice president of global p...
      </title><link>http://www.purchasing.com/podcast/Purchasing_Strategies/1995-Top_CPOs_Audiocast_Gregg_Brandyberry_vice_president_of_global_procurement_systems_and_operations_at_GlaxoSmithKline.php?rssid=20275</link><description>Gregg Brandyberry, vice president of global procurement systems and operations at GlaxoSmithKline, says trying to do more with less becomes more challenging for procurement organizations as global markets change. “Savings and value get more difficult to deliver each year.”</description><guid>http://www.purchasing.com/podcast/Purchasing_Strategies/1995-Top_CPOs_Audiocast_Gregg_Brandyberry_vice_president_of_global_procurement_systems_and_operations_at_GlaxoSmithKline.php?rssid=20275</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Thu, 05 Jul 2007 00:00:00 GMT</pubDate><source url="http://www.purchasing.com" /></item><item><title>GlaxoSmithKline Australia - Prescription Medicines Australia (Pha...
      </title><link>http://www.glaxowellcome.com.au/</link><description>GlaxoSmithKline manufacture and supply pharmaceuticals and are leaders in medical and scientific research and development, within Australia and around the world. We specialise in providing prescription medicines and vaccines supported by quality and timely product information.</description><guid>http://www.glaxowellcome.com.au/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.glaxowellcome.com.au" /></item><item><title>GlaxoSmithKline (GSK) - 10005826 - New Scientist Jobs</title><link>http://www.newscientistjobs.com/jobs/promoteorganisationprofile/science--glaxosmithkline_gsk-10005826.htm</link><description>Add a simple job widget to your website, web page or blog and allow your visitors to see the latest jobs from this organisation. Get the code now - it's free and there's no registration.</description><guid>http://www.newscientistjobs.com/jobs/promoteorganisationprofile/science--glaxosmithkline_gsk-10005826.htm</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.newscientistjobs.com" /></item><item><title>The Hindu Business Line : GlaxoSmithKline to donate swine flu vac...
      </title><link>http://www.thehindubusinessline.com/blnus/02111160.htm</link><description>UNITED NATIONS: The World Health Organization has said pharmaceutical company GlaxoSmithKline (GSM) is to donate 50 million doses of pandemic H1N1 vaccine to the WHO for use in developing countries.</description><guid>http://www.thehindubusinessline.com/blnus/02111160.htm</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 11 Nov 2009 00:00:00 GMT</pubDate><source url="http://www.thehindubusinessline.com" /></item><item><title>TreatHIV</title><link>http://www.treathiv.com/</link><description>Whether you are newly diagnosed with HIV, have been infected with HIV for quite some time, or know someone who is HIV+, now is the time to learn all that you can about HIV medication and treatment. A working partnership with your healthcare provider is the key to successfully treating HIV.</description><guid>http://www.treathiv.com/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.treathiv.com" /></item><item><title>300305_Rev_01_33.qxd</title><link>http://www.reed-elsevier.com/investorcentre/Documents/Annual%20Reports/2004%20-%20annual%20review.pdf</link><description>This document contains the Reed Elsevier Annual Review and Summary Financial Statements 2004 for the Reed Elsevier combined businesses and for Reed Elsevier PLC and Reed Elsevier NV.</description><guid>http://www.reed-elsevier.com/investorcentre/Documents/Annual%20Reports/2004%20-%20annual%20review.pdf</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.reed-elsevier.com" /></item><item><title>HGSI: Conference call regarding Human Genome Sciences and GlaxoSm...
      </title><link>http://www.zibb.com/article/5634023/HGSI+Conference+call+regarding+Human+Genome+Sciences+and+GlaxoSmithKline+Announce+Positive+Results+in+Second+of+Two+Phase+Trials+of+BENLYSTAa+c+in+Systemic+Lupus+Erythematosus+ET+Today+delayed</link><description>Human Genome Sciences Inc (Nasdaq NM : HGSI) will host a conference call regarding Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTAa&amp;bdquo;c in Systemic Lupus Erythematosus.Call Details When : Monday, November 2, 2009 Phone # :</description><guid>http://www.zibb.com/article/5634023/HGSI+Conference+call+regarding+Human+Genome+Sciences+and+GlaxoSmithKline+Announce+Positive+Results+in+Second+of+Two+Phase+Trials+of+BENLYSTAa+c+in+Systemic+Lupus+Erythematosus+ET+Today+delayed</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Mon, 02 Nov 2009 04:15:17 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>GlaxoSmithKline admits false health claims</title><link>http://www.ap-foodtechnology.com/news/ng.asp?n=75278-glaxosmithkline-vitamin-c-nutritional-claims-australian</link><description>Graeme Samuel, Chairman of the Australian competition and Consumer Commission (ACCC), said the company had admitted that certain claims on its labels, including "the blackcurrants in Ribena contain four times the Vitamin C of oranges", were unsubstantiated.</description><guid>http://www.ap-foodtechnology.com/news/ng.asp?n=75278-glaxosmithkline-vitamin-c-nutritional-claims-australian</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.ap-foodtechnology.com" /></item><item><title>GlaxoSmithKline (GKS) announces that the European Commission has ...
      </title><link>http://www.worldpoultry.net/home/id2205-45907/first_pre-ai_pandemic_vaccine_approved_in_eu.html</link><description>GlaxoSmithKline (GKS) announces that the European Commission has granted marketing authorisation for its H5N1 adjuvanted pre-pandemic vaccine, Prepandrix™, in all 27 EU member states.</description><guid>http://www.worldpoultry.net/home/id2205-45907/first_pre-ai_pandemic_vaccine_approved_in_eu.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.worldpoultry.net" /></item><item><title>Pediatric Exclusivity Granted</title><link>http://www.fda.gov/cder/pediatric/exgrant.htm</link><description>This list simply identifies approved active moieties with sponsors to which FDA has granted exclusivity for pediatric studies. Only applications held by the identified sponsor were granted pediatric exclusivity.</description><guid>http://www.fda.gov/cder/pediatric/exgrant.htm</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Wed, 06 May 2009 12:00:00 GMT</pubDate><source url="http://www.fda.gov" /></item><item><title>Copyright © 2009 MarketWatch, Inc. All rights reserved. Please se...
      </title><link>http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&amp;Description=GlaxoSmithKline+plc+&amp;Image=&amp;symb=GSK&amp;sid=2197</link><description>Copyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.</description><guid>http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&amp;Description=GlaxoSmithKline+plc+&amp;Image=&amp;symb=GSK&amp;sid=2197</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.holdrs.com" /></item><item><title>FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine</title><link>http://www.bio-medicine.org/medicine-technology-1/FDA-Approves-Cervarix--GlaxoSmithKlines-Cervical-Cancer-Vaccine-5527-1/</link><description>...PHILADELPHIA Oct. 16 /- GlaxoSmithKline (NYSE:... The approval of CERVARIX will bring an important new cervical cancer ...CERVARIX was shown to be 93 percent efficacious in the prevention of c...The impact of CERVARIX against the overall burden of HPV-related</description><guid>http://www.bio-medicine.org/medicine-technology-1/FDA-Approves-Cervarix--GlaxoSmithKlines-Cervical-Cancer-Vaccine-5527-1/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Fri, 16 Oct 2009 15:55:53 GMT</pubDate><source url="http://www.bio-medicine.org" /></item><item><title>IBM RD 50-6 | The Pathway Editor: A tool for managing complex bio...
      </title><link>http://www.research.ibm.com/journal/rd/506/sorokaut.html</link><description>inf.ed.ac.uk). Dr. Sorokin is a Research Fellow in the Computational Systems Biology Group at the University of Edinburgh. In 1995 he received an M.Sc. degree from the Moscow Institute of Physics and Technology and in 2000 a Ph.D.</description><guid>http://www.research.ibm.com/journal/rd/506/sorokaut.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.research.ibm.com" /></item><item><title>U:\NFP\NFP410May\NFP410May.vp</title><link>http://www.elsevier.com/framework_products/NFP_csv/nfp2005-may.pdf</link><description>Advances in Quantum Chemistry, 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 The Alkaloids, 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 The Alkaloids, 62 . . . . . . . . . . . . . .</description><guid>http://www.elsevier.com/framework_products/NFP_csv/nfp2005-may.pdf</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.elsevier.com" /></item><item><title>Changing the Debate on Healthcare Costs in the US,GlaxoSmithKline...
      </title><link>http://www.cfo.com/whitepapers/index.cfm/displaywhitepaper/13562348</link><description>Rising healthcare costs rank high on the list of concerns for most Americans. As costs increase, some employers are asking employees to shoulder a larger share.</description><guid>http://www.cfo.com/whitepapers/index.cfm/displaywhitepaper/13562348</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate>Fri, 24 Apr 2009 00:00:00 GMT</pubDate><source url="http://www.cfo.com" /></item><item><title>Apria - resources - News</title><link>http://www.apria.com/resources/1,2725,494-862883-3,00.html</link><description>Ligand Pharmaceuticals Inc (NASDAQ:LGND), which discovers and develops new drugs that address critical unmet medical needs, said on 18 December that the company has signed an exclusive, worldwide license agreement with GlaxoSmithKline (GSK) (NYSE:GSK) for LGD-4665 product candidate.</description><guid>http://www.apria.com/resources/1,2725,494-862883-3,00.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.apria.com" /></item><item><title>GLAXOSMITHKLINE User's Holdings GSK GSK.L - Interactive Investor</title><link>http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&amp;display=community&amp;it=le</link><description>0845 88 00 267. Registered in England with Company Registration number 3699618. Group VAT registration number 832 6732 26. We may record and/or monitor telephone calls or intercept other telecommunications between us. This is to protect both of us and for training purposes.</description><guid>http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&amp;display=community&amp;it=le</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.iii.co.uk" /></item><item><title>GlaxoSmithKline | Company Information from ICIS</title><link>http://www.icis.com/v2/companies/9145277/glaxosmithkline.html</link><description>GlaxoSmithKline (GSK) is a research-based pharmaceutical and healthcare company engaged in pharmaceutical products, vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK is involved in four major therapeutic areas - anti-infectives, central nervous system (CNS),</description><guid>http://www.icis.com/v2/companies/9145277/glaxosmithkline.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.icis.com" /></item><item><title>Reports: GlaxoSmithKline to cut thousands of jobs - Forbes.com</title><link>http://www.forbes.com/feeds/ap/2009/02/01/ap5992260.html</link><description>The Sunday Telegraph said up to 6,000 posts would be eliminated around the world. The Observer said as many as 10,000 jobs could go - 10 percent of the company's global work force.</description><guid>http://www.forbes.com/feeds/ap/2009/02/01/ap5992260.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.forbes.com" /></item><item><title>Vaccines: VFC/CDC Vaccine Price List</title><link>http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htm</link><description>Note The CDC Vaccine Price Lists posted on this website provide current vaccine contract prices and list the private sector vaccine prices for general information.</description><guid>http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htm</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.cdc.gov" /></item><item><title>GlaxoSmithKline - Planning Services | Experience | Faithful+Gould...
      </title><link>http://www.fgould.com/uk/experience/sheet/glaxosmithkline-planning-services/</link><description>To provide planning engineering services for over five years and continue to support GSK’s Master Plan and the Major Projects Production, Research and Development departments of GlaxoSmithKline and at Barnard Castle, County Durham.</description><guid>http://www.fgould.com/uk/experience/sheet/glaxosmithkline-planning-services/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.fgould.com" /></item><item><title>Press Release - VeriSign UK Ltd.</title><link>http://www.verisign.co.uk/verisign-inc/page_031893.html</link><description>October 26, 2005 VeriSign and the Worldwide Retail Exchange (WWRE) today announced an agreement to offer point-of-sale (POS) data services to WWRE members creating more timely access, exchange, and management of information throughout the $8 trillion global retail supply chain.</description><guid>http://www.verisign.co.uk/verisign-inc/page_031893.html</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.verisign.co.uk" /></item><item><title>GlaxoSmithKline Plc. - Summer Talent Identification Program / Ana...
      </title><link>http://www.aiche.org/sbe/career/jobpostings/AnalyticalDevelopment.aspx</link><description>GlaxoSmithKline, the world’s second largest pharmaceutical company, seeks to recruit high caliber university students for its Summer Talent Identification Program (STIP).</description><guid>http://www.aiche.org/sbe/career/jobpostings/AnalyticalDevelopment.aspx</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.aiche.org" /></item><item><title>Children's Panadol</title><link>http://www.childrenspanadol.com.au/competition/terms.aspx</link><description>Your use and/or continued access to the Website constitutes your agreement to the Conditions of Use. GSKA reserves the right to amend the Conditions of Use at any time. The amended terms and conditions will be effective immediately.</description><guid>http://www.childrenspanadol.com.au/competition/terms.aspx</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.childrenspanadol.com.au" /></item><item><title>Packaging Technology - GlaxoSmithKline Bottling Line Upgrade, Col...
      </title><link>http://www.packaging-technology.com/projects/gskbottling/</link><description>GlaxoSmithKline (GSK) is a well-known UK-based pharmaceutical company with interests in pharmaceuticals spread right across the world. One of the legacies of the company is an established health drinks division that produces the popular and lucrative brands Ribena and Lucozade.</description><guid>http://www.packaging-technology.com/projects/gskbottling/</guid><category domain="http://www.zibb.com">GlaxoSmithKline</category><pubDate /><source url="http://www.packaging-technology.com" /></item></channel></rss>